Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.
Alveolar soft-part sarcoma ... tumor-mimicking chip to reproduce the natural functions of human endothelial cells and ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
During tests on mice, the researchers found that the sweet vape interfered with cells called alveolar macrophages and prevented them from clearing out bacteria. The researchers say that this could ...
Unresectable alveolar soft part sarcoma has a poor prognosis, and no standard treatment has been established. Tecentriq is a cancer immune checkpoint inhibitor targeting PD-L1, which is a protein ...